---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-167951"
form_type: "8-K"
ticker: "MIRM"
cik: "0001759425"
company_name: "Mirum Pharmaceuticals, Inc."
filed_at: "2022-06-06T23:59:59+00:00"
generated_at: "2026-06-25T04:26:00.558429+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Mirum appoints Saira Ramasastry to board; stockholders re-elect three directors

## Summary
- Saira Ramasastry appointed to Mirum's board effective June 2, 2022; will serve on audit committee.
- Ramasastry received option to purchase 34,000 shares vesting over three years; annual cash retainers of $40k (board) and $10k (audit).
- At annual meeting, stockholders re-elected directors Laura Brege, Michael Grey, and Christopher Peetz to Class III terms expiring 2025.
- Stockholders ratified Ernst & Young as independent auditor for FY2022 with overwhelming support.

## SEC filing metadata
- accession: 0001193125-22-167951
- form_type: 8-K
- ticker: MIRM
- cik: 0001759425
- company_name: Mirum Pharmaceuticals, Inc.
- filed_at: 2022-06-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759425/000119312522167951/0001193125-22-167951-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759425/000119312522167951/d309554d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-167951
- JSON: https://secwatch.observer/filing/0001193125-22-167951.json
- Plain text: https://secwatch.observer/filing/0001193125-22-167951.txt

## Key facts
- Executive change
  Saira Ramasastry was appointed as Director at Mirum Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Director
  source text: On June 2, 2022, the Board of Directors (the "Board") of Mirum Pharmaceuticals, Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Saira Ramasastry to the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759425/000119312522167951/0001193125-22-167951-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.